Thoughts and information about the latest news in the world of migraine, cluster headache and other headache treatment around the world.
sodium valproate (Epival)paroxetine (Paxil)metoprolol (Toprol-XL)divalproex sodium (Depakote)amitriptyline (Elavil) DO NOT stop taking medication without talking to your doctor.DO talk to your doctor if you’re gaining weight – there are options available. These are medications that are often used as migraine preventatives – and often help – but that are also notorious for contributing to weight [...]
{ 2 comments }
I’ve been getting a lot of questions regarding the ginger and sumatriptan study, so we’re going to take the time to talk about a few more details. Obviously one study is not enough to change treatment practices around the world. However, the researchers were motivated to study ginger because it had already shown great promise [...]
{ 1 comment }
It was only last month that we talked about taking ginger to fight the pain of headache and migraine, as well as other symptoms. Actually, ginger has long been a popular treatment for nausea, which is used regularly by doctors. But a recent study in the journal Phytotherapy Research set out to investigate ginger specifically [...]
{ 12 comments }
Migraine in Kids and Teens, Dangerous Herbs, and Migraine Brains [ 7 min 44 s ] Play Now | Play in Popup | DownloadToday’s podcast covers some recent migraine news. Here are some of the links mentioned: Topiramate in pediatric migraine Trigger factors reported by adolescents with migraine Childhood migraine tied to history of infantile colic Popular Chinese medicine used for migraines could be FATAL, warn health watchdogs Migraine sufferers likely have brain abnormalities, study finds
{ 0 comments }
Levadex, an inhaled version of dihydroergotamine mesylate (DHE), has been rejected again by the FDA in the United States due to manufacturing concerns. Levadex was recently at the centre of a deal worth almost a billion, when Allergan bought MAP Pharmaceuticals, the developers of the drug. Just over a year ago, with MAP at the [...]
{ 2 comments }
Loading ...
